StockData
GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

GLAUKOS Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$166.96+2.12 (+1.29%)

Close on Oct 19, 2026

Market cap
$9.82B
P/E (TTM)
–
Dividend yield
–

Earnings

Next report expected Oct 28, 2026, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Jul 29, 2026After market close$185.60M$-0.31–
Q1 FY2026
Ended Mar 31, 2026
Apr 29, 2026After market close$150.60M$-0.34$-0.18
Q4 FY2025
Ended Dec 31, 2025
Jan 13, 2026After market close$143.00M––
Q3 FY2025
Ended Sep 30, 2025
Oct 29, 2025After market close$133.50M$-0.28$-0.16
Q2 FY2025
Ended Jun 30, 2025
Jul 30, 2025After market close$124.10M$-0.34$-0.24
Q1 FY2025
Ended Mar 31, 2025
Apr 30, 2025After market close$106.70M$-0.32$-0.22
Q4 FY2024
Ended Dec 31, 2024
Feb 20, 2025After market close$105.50M$-0.60$-0.40
Q3 FY2024
Ended Sep 30, 2024
Nov 4, 2024After market close$96.70M$-0.39$-0.28
Q2 FY2024
Ended Jun 30, 2024
Jul 31, 2024After market close–––
Q1 FY2024
Ended Mar 31, 2024
May 1, 2024After market close–––
Q4 FY2023
Ended Dec 31, 2023
Jan 9, 2024Before market open–––

Company guidance

Outlook given with results on Jul 29, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
net sales2026$680.00M to $700.00MRaised

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Glaukos filed with the SEC